Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial

Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial

Abstract Objective To investigate the effects of metformin (MET) monotherapy and pioglitazone plus MET (PIOMET) therapy on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome (PCOS). Methods Sixty normal-weight women with PCOS were recruited between January and Septe...

Full description

Bibliographic Details
Main Authors: Han Zhao, Jiaqi Zhang, Chuan Xing, Xiangyi Cheng, Bing He
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Journal of Ovarian Research
Subjects:
Polycystic ovary syndrome
Normal-weight
Metformin
Pioglitazone
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13048-024-01367-7

Internet

https://doi.org/10.1186/s13048-024-01367-7

Similar Items